Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Extended-release oxycodone
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
2Oxycodone
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[7] 6, 13, 46, 70, 226, 231, 298 💬
3Oxycodone by patient-controlled analgesia (PCA)
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 46 💬
4Oxycodone Depot ”Sandoz”, depot tablets
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298 💬
5OXYCODONE HYDROCHLORIDE
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298 💬
6Oxycodone naloxone prolonged release tablets
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
7Oxycodone Orion
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
8Oxycodone/Acetaminophen
(D03783)		[2] Acetaminophen,
Oxycodone		[4] Acetaminophen ,
Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[5] OPRD1,
OPRK1,
OPRM1,
PTGS1,
PTGS2 💬 		[30] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Estrogen signaling pathway, Hormone signaling, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 💬[1] 231 💬
9Oxycodone/naloxone prolonged release t
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
10Oxycodone/Naloxone Prolonged Release tablets
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
11Oxycodone/naloxone prolonged release tablets 10 mg /5 mg
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
12Oxycodone/naloxone prolonged release tablets 10/5 mg
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
13Oxycodone/naloxone prolonged release tablets 20 mg /10 mg
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
14Oxycodone/naloxone prolonged release tablets 20/10 mg
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
15Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
16Oxycodone/naloxone prolonged release tablets 5/2.5 mg
(D03783)		[2] Naloxone,
Oxycodone		[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
17PR Oxycodone
(D03783)		[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate (D03783),
Oxycodone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬